Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Parallel-group Comparison, Investigators Initiated Phase II Clinical Trial of IDEC-C2B8 (Rituximab) in Patients With Systemic Sclerosis

NCT04274257 is registered in ClinicalTrials.gov with Tokyo University as lead sponsor.

NCT NCT04274257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04274257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Parallel-group Comparison, Investigators Initiated Phase II Clinical Trial of IDEC-C2B8 (Rituximab) in Patients With Systemic Sclerosis
Lead sponsor
Tokyo University
Phase
Phase 2/3
Overall status
Completed
Start date
December 4, 2017
Completion date
November 5, 2019
Enrollment
56 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, collagen diseases, lung fibrosis, scleroderma, systemic, skin sclerosis